跳至主要内容
临床试验/NCT01071889
NCT01071889已完成1 期

Double-blind, Randomized, Placebo and Active Controlled Study to Assess the Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults(Zolpidem or Brotizolam)

Coeruleus Ltd.1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
1
主要终点
Safety of single dose administration of sublingual Flumazenil 0.4 mg as a reversal drug for the hypnotic effect of sleep/ hypnotic drugs

研究概览

简要总结

The purpose of this study is to evaluate the safety and effectiveness of treatment with sublingual (s/l) Flumazenil in healthy volunteers as reversing the effect of the sleep/hypnotic drugs. This study is designed to collect short-term safety and tolerability data.

In addition, the psychomotor/ cognitive and behavioral effects of Flumazenil will be assessed to monitor the degree and the duration of action in a single use of Flumazenil.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The subject understood and voluntarily signed an informed consent form prior to any study-mandated procedure.
  • Male or female aged 18-65 at screening. Women of childbearing potential must have a negative pregnancy test at the screening visit and use a reliable method of contraception during the entire study duration (e.g.
  • Contraceptive pill; Intra-uterine device; Contraceptive injection (prolonged-release gestagen); Subdermal implantation;Vaginal ring or Transdermal patch).
  • Body mass index ≥ 18.5 and < 32 kg/m
  • Normal sleep habits, i.e. usual self-reported total sleep time > 6 h; usual self-reported time to fall asleep < 30 min; usual bedtime between 10:30 pm and 01:00 am.
  • Subject is in good health as determined by a medical history, physical examination and ECG.
  • Negative any use of illicit drug, alcohol (ethanol), stimulants.

排除标准

  • Any use of medications within 1 month prior to screening visit, except for contraceptive pills.
  • Any sleep associated complains.
  • Previous exposure to Benzodiazepines and/or non-Benzodiazepine hypnotic drugs within 3 months prior to study initiation.
  • History of Epilepsy and or anti-epileptic drugs.
  • Excessive caffeine consumption (≥ 500 mg per day).
  • Pregnancy or breast feeding.
  • Night shift workers within 1 month prior to the screening visit.
  • Clinically relevant ECG abnormalities.
  • History of alcohol or drug abuse within 3 years prior to the screening visit.
  • Cognitive Behavioral Therapy (CBT) started within 1 month prior to the screening visit.
  • Known hypersensitivity to drugs of the same class as the study treatment, or any excipients of the drug formulation.
  • Treatment with another investigational drug within 1 month prior to the screening visit.
  • History of severe head injury.

研究组 & 干预措施

Brotizolam

Other

Treatment response will be evaluated for each treatment arm. Good Response (GR) - is considered as an improvement of 30% in efficacy parameters of Flumazenil treatment in comparison to placebo

干预措施: Flumazenil (Drug)

Brotizolam

Other

Treatment response will be evaluated for each treatment arm. Good Response (GR) - is considered as an improvement of 30% in efficacy parameters of Flumazenil treatment in comparison to placebo

干预措施: Placebo (Drug)

Zolpidem

Other

Treatment response will be evaluated for each treatment arm. Good Response (GR) - is considered as an improvement of 30% in efficacy parameters of Flumazenil treatment in comparison to placebo.

干预措施: Flumazenil (Drug)

Zolpidem

Other

Treatment response will be evaluated for each treatment arm. Good Response (GR) - is considered as an improvement of 30% in efficacy parameters of Flumazenil treatment in comparison to placebo.

干预措施: Placebo (Drug)

结局指标

主要结局

Safety of single dose administration of sublingual Flumazenil 0.4 mg as a reversal drug for the hypnotic effect of sleep/ hypnotic drugs

时间窗: 6 months

次要结局

  • Efficacy of single dose administration of sublingual Flumazenil 0.4 mg as a reversal drug for the hypnotic effect of sleep/ hypnotic drugs(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验